Daly JW. Caffeine analogs: biomedical impact. Cell Mol Life Sci. 2007;64:2153-2169.

Fredholm BB, Battig K, Holmen J. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51:83-133.

Goldstein J, Silberstein SD, Saper JR. Acetaminophen, aspirin and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double- blind, randomized, parallel-group, single-dose, placebo- controlled study. Headache. 2006;46:444-453.

Sawynok J. Methylxanthines and pain. Handb Exp Pharmacol. 2011;200:311-329.

Schmidt B, Roberts RS, Davis P. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354:2112-2121.

Sawynok J, Yaksh TL. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev. 1993;45:43-85.

Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology. 2004;176:1-29.

Ribeiro JA, Sebastião AM. Caffeine and adenosine. J Alzh Dis. 2010;20:S3-S15.

Davis JK, Green JM. Caffeine and anaerobic performance: ergogenic value and mechanisms of action. Sports Med. 2009;39(10):813-832.

Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet. 2000;39(2):127-153.

Shi D, Padgett WL, Daly JW. Caffeine analogs: effects on ryanodine-sensitive calcium-release channels and GABAa receptors. Cell Mol Neurobiol. 2003;23:331-347.

Sawynok J. Caffeine and pain. Pain. 2010.

Sawynok J, Reid AR, Fredholm BB. Caffeine reverses antinociception by amitriptyline in wild type mice but not in those lacking adenosine A1 receptors. Neurosci Lett. 2008;440(2):181-184.

Castro A, Jerez MJ, Gil C. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors. Med Res Rev. 2005;25:229-224.

Cheng LZ, Lü N, Zhang YQ. Ryanodine receptors contribute to the induction of nociceptive input-evoked long-term potentiation in the rat spinal cord slice. Mol Pain. 2010;20:1-6.

Cauli O, Morelli M. Caffeine and the dopaminergic system. Behav Pharmacol. 2005;16:63-77.

Xu K, Bastia E, Schwarschild M. Therapeutic potential of adenosine A2a receptor antagonists in Parkinson's disease. Drugs Aging. 2005;22:471-482.

Maia L, De Mendonça A. Does caffeine intake protect from Alzheimer disease?. Eur J Neurol. 2002;9:377-382.

Arendash GW, Schleif W, Rezai-Zadeh K. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience. 2006;142:941-952.

Yang H, Rouse J, Lukes L. Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis. Clin Exp Metastasis. 2004;21:719-735.

Petrie HJ, Chown SE, Belfie LM. Caffeine ingestion increases the insulin response to na oral-glucose- tolerance test in obese men before and after weight loss. Am J Clin Nutr. 2004;80:22-28.

Zhang W Y. A benefit- risk assessment of caffeine as an analgesic adjuvant. Drug Safety. 2001;24:1127-1142.

Mercadante S, Serretta R, Casuccio A. Effects of Caffeine as an adjuvant to morphine in advanced cancer patients: a randomized, double-blind, placebo-controlled, crossover study. J Pain Symptom Manage. 2001;21(5):369-372.

Peroutka S, Lyon JA, Swarbrick J. Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study. Headache. 2004;44:136-141.

Diamond S, Balm TK, Freitag FG. Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther. 2000;68(3):312-319.

Renner B, Clarke G, Grattan T. Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. J Clin Pharmacol. 2007;47:715-726.

Ewans RW, Armon C, Frohman EM. Assessment: prevention of post-lumbar puncture headaches. Neurology. 2000;55:909-914.

Lin W, Geiderman J. Myth: fluids, bed rest, and caffeine are effective in preventing and treating patients with post-lumbar puncture headache. West J Med. 2002;176(1):69-70.

Palmer H, Graham G, Williams K. A risk-benefit assessment of paracetamol (acetaminophen) combined with caffeine. Pain Med. 2010;11(6):951-965.

Feinstein AR, Heinemann LA, Dalessio D. Do caffeine-containing analgesics promote dependence?: A review and evaluation. Clin Pharmacol Ther. 2000;68(5):457-467.

Morelli M, Simola N. Methylxantines and drug dependence: a focus on interactions with substances of abuse. Handb Exp Pharmacol. 2011;200:483-507.